Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas

Oncology Reports

Volumn 20, Issue 3, 2008, Pages 573-579

  Li, Haiyan ^a   Wang, Qun ^a   Gao, Fei ^a   Zhu, Faliang ^a   Wang, Xiaoyan ^a   Zhou, Chengjun ^b   Liu, Chunmei ^a   Chen, Yingyu ^c   Ma, Chunhong ^a   Sun, Wensheng ^a   Zhang, Lining ^a  

^a SHANDONG UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

Gene expression; Glioma; Programmed cell death 5

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; MESSENGER RNA; PROGRAMMED CELL DEATH 5 PROTEIN; UNCLASSIFIED DRUG; PDCD5 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; CARCINOGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BRAIN TUMOR; CANCER STAGING; CELL CULTURE; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; PATHOLOGY; SURVIVAL RATE;

ADULT; APOPTOSIS REGULATORY PROTEINS; ASTROCYTOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 54549113137     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or_00000044     Document Type: Article

References (20)

1. Liu HT, Wang YG, Zhang YM, et al: TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 254: 203-210, 1999.
2. Zhang YM, Xu XZ, Liu HT, Song QS and Ma DL: The apoptosis-accelerating effect of human recombinant TFAR19 protein on leukemia HL-60 cells. J Chin Immunol 16: 8-11, 2000.
3. Rui M, Chen YY, Zhang YM and Ma DL: Transfer of anti-TFAR19 monoclonal antibody into HeLa cells by in situ electroporation can inhibit the apoptosis. Life Sci 71: 1771-1778, 2002.
4. Wang Y, Li XT, Wang L, Ding PG, Zhang YM, Han WL and Ma DL: An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 over-expression. J Cell Sci 117: 1525-1532, 2004.
5. Yang YH, Zhao M, Li WM, Chen YY, Kang B and Lu YY: Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis 11: 993-1001, 2006.
6. Spinola M, Meyer P, Kammerer S, et al: Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. J Clin Oncol 24: 1672-1678, 2006.
7. Tan WL, Xiong L, Zheng SB, Yu ZC, Qi H, Du YJ and Wu P: Relationship between programmed cell death 5 protein expression and prognosis of renal clear cell carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 26: 1316-1318, 2006.
8. Liu ZH, Zhang D, Li KM and Liao QP: Expression of PDCD5 in tissues of normal cervix, CIN I-III and cervical cancer. Beijing Da Xue Xue Bao 36: 407-410, 2004.
9. Xu XR, Huang J, Xu ZG, et al: Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 98: 15089-15094, 2001.
10. Ruan GR, Qin YZ, Chen SS, et al: Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leukemia Res 30: 1159-1165, 2006.
11. Bansal K, Liang ML and Rutka JT: Molecular biology of human gliomas. Technol Cancer Res Treat 5: 185-194, 2006.
12. Nakabayashi H, Hara M and Shimuzu K: Clinicopathologic significance of cystatin C expression in gliomas. Hum Pathol 36: 1008-1015, 2005.
13. Perunovic B, Athanasiou A, Quilty RD, Gorgoulis VG, Kittas C and Love S: Expression of mos in astrocytic tumors and its potential role in neoplastic progression. Hum Pathol 33: 703-707, 2002.
14. Gao F, Zhang P, Zhou C, Li J, Wang Q, Zhu F, Ma C, Sun W and Zhang L: Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. Oncol Rep 17: 123-128, 2007.
15. Chadderton T, Wilson C, Bewick M and Gluck S: Evaluation of three rapid RNA extraction reagents: relevance for use in RT-PCR's and measurement of low level gene expression in clinical samples. Cell Mol Biol 43: 1227-1234, 1997.
16. Culley DE, Kovacik WP Jr, Brockman FJ and Zhang W: Optimization of RNA isolation from the archaebacterium Methanosarcina barkeri and validation for oligonucleotide microarray analysis. J Microbiol Methods 67: 36-43, 2006.
17. Dai DL, Martinka M and Li G: Prognostic significance of activated Akt expression in melanoma: a clinico-pathologic study of 292 cases. J Clin Oncol 23: 1473-1482, 2005.
18. Sun CL, Qiao J, Hu ZX, Zhang T and Chen YY: Expression of novel apoptosis-related protein PDCD5 in granulosa cells of polysystic ovary syndrome. Beijing Da Xue Xue Bao 37: 476-479, 2005.
19. McCabe ML and Dlamini Z: The molecular mechanisms of oesophageal cancer. Int Immunopharmacol 5: 1113-1130, 2005.
20. Kountouras J, Zavos C and Chatzopoulos D: Apoptotic and anti-angiogenic strategies in liver and gastrointestinal malignancies. J Surg Oncol 90: 249-259, 2005.